4//SEC Filing
Feinsod Matthew 4
Accession 0001273636-19-000022
CIK 0001273636other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 8:28 PM ET
Size
5.9 KB
Accession
0001273636-19-000022
Insider Transaction Report
Form 4
Feinsod Matthew
Interim Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2019-07-29+100,000→ 100,000 totalExercise: $3.91Exp: 2029-07-29→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Option becomes exercisable based on the achievement of certain performance milestones. For each milestone met, the option vests as to 16,666.6667 shares of the Company's common stock in accordance with the following schedule: 25% of the underlying shares for such milestone vest on achievement of such milestone, and thereafter the remaining underlying shares for such milestone vest in equal monthly installments over three years, resulting in the option being exercisable for 100% of the underlying shares for such milestone on the third anniversary of the achievement of the applicable milestone.
Documents
Issuer
APPLIED GENETIC TECHNOLOGIES CORP
CIK 0001273636
Entity typeother
Related Parties
1- filerCIK 0001716950
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 8:28 PM ET
- Size
- 5.9 KB